EUVIMEDEUVIMED entdecken
Open Access · CC BY-NC-ND 4.0

Influence of Polygenic Background on the Clinical Presentation of Familial Hypercholesterolemia

Mark Trinder iD, Lubomira Cermakova, Isabelle Ruel iD, Alexis Baass iD, Martine Paquette iD, Jian Wang iD, Brooke A Kennedy, Robert A Hegele iD, Jacques Genest iD, Liam R Brunham iD

Arteriosclerosis, Thrombosis, and Vascular Biology · 2024

DOI: 10.1161/atvbaha.123.320287 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Arteriosclerosis, Thrombosis, and Vascular Biology, 2024. Verfasst von Mark Trinder und 9 weiteren Autor:innen. Beteiligte Einrichtung: Centre for Heart Lung Innovation, University of British Columbia and St. Paul's Hospital, Vancouver, Canada (M.T., L.C., L.R.B.). Hauptthemen laut MEDLINE: Hyperlipoproteinemia Type II, Multifactorial Inheritance, Cholesterol, LDL, Phenotype. Die Arbeit wurde bisher 9-mal zitiert (Crossref) und nennt 49 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY-NC-ND 4.0).

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

BACKGROUND: Heterozygous familial hypercholesterolemia (FH) is among the most common genetic conditions worldwide that affects ≈ 1 in 300 individuals. FH is characterized by increased levels of low-density lipoprotein cholesterol (LDL-C) and increased risk of coronary artery disease (CAD), but there is a wide spectrum of severity within the FH population. This variability in expression is incompletely explained by known risk factors. We hypothesized that genome-wide genetic influences, as represented by polygenic risk scores (PRSs) for cardiometabolic traits, would influence the phenotypic severity of FH. METHODS: We studied individuals with clinically diagnosed FH (n=1123) from the FH Canada National Registry, as well as individuals with genetically identified FH from the UK Biobank (n=723). For all individuals, we used genome-wide gene array data to calculate PRSs for CAD, LDL-C, lipoprotein(a), and other cardiometabolic traits. We compared the distribution of PRSs in individuals with clinically diagnosed FH, genetically diagnosed FH, and non-FH controls and examined the association of the PRSs with the risk of atherosclerotic cardiovascular disease. RESULTS: Individuals with clinically diagnosed FH had higher levels of LDL-C, and the incidence of atherosclerotic cardiovascular disease was higher in individuals with clinically diagnosed compared with genetically identified FH. Individuals with clinically diagnosed FH displayed enrichment for higher PRSs for CAD, LDL-C, and lipoprotein(a) but not for other cardiometabolic risk factors. The CAD PRS was associated with a risk of atherosclerotic cardiovascular disease among individuals with an FH-causing genetic variant. CONCLUSIONS: Genetic background, as expressed by genome-wide PRSs for CAD, LDL-C, and lipoprotein(a), influences the phenotypic severity of FH, expanding our understanding of the determinants that contribute to the variable expressivity of FH. A PRS for CAD may aid in risk prediction among individuals with FH.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Hyperlipoproteinemia Type IIMultifactorial InheritanceCholesterol, LDLPhenotypeRegistriesGenetic Predisposition to DiseaseCoronary Artery DiseaseGenome-Wide Association StudyLipoprotein(a)HumansFemaleMaleMiddle AgedRisk AssessmentAdultAgedCanadaUnited KingdomSeverity of Illness IndexRisk FactorsCase-Control StudiesBiomarkersIncidence

Stichwörter der Autor:innen

biological specimen bankscardiovascular diseasescholesterol, LDLcoronary artery diseasegenetic risk score

Substanzen

Cholesterol, LDLLipoprotein(a)BiomarkersLPA protein, human

Autor:innen und Institutionen

  • Centre for Heart Lung Innovation, University of British Columbia and St. Paul's Hospital, Vancouver, Canada (M.T., L.C., L.R.B.).
  • Research Institute of the McGill University Health Centre, Montreal, Canada (I.R., J.G.).
  • Montreal Clinical Research Institute, Canada (A.B., M.P.).
  • Departments of Medicine and Biochemistry, Schulich School of Medicine and Robarts Research Institute, Western University, London, Canada (J.W., B.A.K., R.A.H.).
  • Departments of Medicine and Medical Genetics, University of British Columbia, Vancouver, Canada (L.R.B.).

ORCID-Profile: Mark Trinder, Isabelle Ruel, Alexis Baass, Martine Paquette, Jian Wang, Robert A Hegele, Jacques Genest, Liam R Brunham

Zitieren

APA

Trinder, M., Cermakova, L., Ruel, I., Baass, A., Paquette, M., Wang, J., Kennedy, B. A., Hegele, R. A., Genest, J., & Brunham, L. R. (2024). Influence of Polygenic Background on the Clinical Presentation of Familial Hypercholesterolemia. Arteriosclerosis, Thrombosis, and Vascular Biology. https://doi.org/10.1161/atvbaha.123.320287

Vancouver

Trinder M, Cermakova L, Ruel I, Baass A, Paquette M, Wang J, et al. Influence of Polygenic Background on the Clinical Presentation of Familial Hypercholesterolemia. Arteriosclerosis, Thrombosis, and Vascular Biology. 2024. doi:10.1161/atvbaha.123.320287

BibTeX
@article{Trinder2024,
  author = {Trinder, Mark and Cermakova, Lubomira and Ruel, Isabelle and Baass, Alexis and Paquette, Martine and Wang, Jian and Kennedy, Brooke A and Hegele, Robert A and Genest, Jacques and Brunham, Liam R},
  title = {Influence of Polygenic Background on the Clinical Presentation of Familial Hypercholesterolemia},
  journal = {Arteriosclerosis, Thrombosis, and Vascular Biology},
  year = {2024},
  doi = {10.1161/atvbaha.123.320287}
}
Kostenlos starten →